Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: TheBusDriver who wrote (11350)	11/7/2002 1:21:12 AM
From: Cal Gary	Read Replies (2) \| Respond to of 14101

Is there a doctor in the house? Yuk yuk... Is there a medical person who can elaborate a bit further on the following copied from wf10.com , especially the items marked in bold fonts: "NEW PATIENTS AS OF NOVEMBER 3 I am pleased to report that I am presently treating 2 M.S. patients and one multiple allergy patient with fatigue sx who is improving after her 2nd cycle and is now on her 3rd cycle. MS. patients continue to be non-progressive which I believe should be inferred to be successful. Regression will take much longer. I await the upcoming phase three results with great anticipation, and also the imminent approval of Pennsaid " ibid the last two items in the last sentence! Great news for MS suffers if WF10 is truly effective! Unfortunately, DMX has no clinical underway for this indication. Sad. Please correct me if I am wrong. Long live the "special access" program. Thank you in advance.